FDA approves Diclegis for pregnant women who have nausea and vomiting

Author(s):

On April 8, the U.S. Food and Drug Administration (FDA) approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) to treat pregnant women experiencing nausea and vomiting. Diclegis is a delayed-release tablet intended for women who have not adequately responded to conservative management of nausea and vomiting during pregnancy, such as dietary and lifestyle modifications. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here